Cornelia Bargmann will be nominated by AstraZeneca shareholders as a non-executive director at the company’s annual general meeting on April 24. The Board of Directors is also proposing the appointment of Bargmann to AstraZeneca’s Science Committee.
John Varley, senior independent non-executive director, and Nancy Rothwell, non-executive director, both intend to retire from the Board of Directors at the end of the meeting on April 24. Varley and Rothwell have been on the Board of Directors for nine years.
Rothwell is also the chairman of the Science Committee, while Varley is the chairman of the Remuneration Committee and a member of the Nomination and Governance Committee.